Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial.

Alasdair J ColesDouglas L ArnoldAnn D BassAaron L BosterD Alastair S CompstonÓscar FernándezEva Kubala HavrdováKunio NakamuraAnthony TraboulseeTjalf ZiemssenAlan JacobsDavid H MargolinXiaobi HuangNadia DaizadehMadalina C ChirieacKrzysztof W Selmaj

Published in: Therapeutic advances in neurological disorders (2021)

NCT00530348; NCT00548405; NCT00930553.

Keyphrases

healthcare
mass spectrometry
palliative care
multiple sclerosis
study protocol
clinical trial
phase iii
ms ms
quality improvement
phase ii
randomized controlled trial
pain management
open label
chronic pain